skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

46 Total results for product and free and sample content found

Business development and licensing Business and portfolio strategy Competitive and market intelligence

Datamonitor Healthcare

Explore future changes in the multiple sclerosis market

08 Nov 2016

Increase your knowledge of the multiple sclerosis (MS) market by taking a tour of the key highlights from our forecast report

Clinical trial intelligence Regulatory approval Business development and licensing

Datamonitor Healthcare

Ensure your successful entrance into the ovarian cancer market in the seven major markets

25 Oct 2016

Combine the strengths or Trialtrove and Datamonitor Healthcare to ensure your successful entrance into the ovarian cancer market in the 7 major markets

Topics Brexit

Clinical trial intelligence Regulatory approval Business development and licensing

Datamonitor Healthcare

An exploration Rheumatoid Arthritis overview

20 Oct 2016

Despite key markets pressures, the rheumatoid arthritis (RA) market is forecast to continue to grow over the next 10 years. Our RA coverage highlights where the opportunities remain, with a detailed look into the future of the RA treatment.

Topics Arthritis

Clinical trial intelligence Regulatory approval Business development and licensing

Datamonitor Healthcare

Future market dynamics in type 2 diabetes

20 Oct 2016

With the type two diabetes market undergoing unprecedented changes its important to know how this will shape the future dynamics of this competitive market. With our coverage you're able to analyse every aspect of this market.

Topics Diabetes

Clinical trial intelligence Regulatory approval Business development and licensing

Datamonitor Healthcare

The evolving landscape of biosimilars

20 Oct 2016

It is important to understand how the biosimilar market has developed over the past five years. Take a look at some of the key events here.

Topics Biosimilars

RxScorecard

Explore an interactive roadmap to market access, from the payer’s perspective

11 Oct 2016

RxScorecard™ is the first and only tool to assess the value of marketed and pipeline drugs – objectively, systematically, transparently – from the payer’s point of view.

Topics Reimbursement

Business and portfolio strategy Competitive and market intelligence

Datamonitor Healthcare

Ensure your successful entrance into the Hepatitis B market

By Michael ​ Haydock 01 Jul 2016

Entering a established market as a new player can be daunting. It's difficult to know exactly where you should be targeting your trial, and also who you should be targeting your treatment at.

Topics Hepatitis B Hepatitis

Business and portfolio strategy Competitive and market intelligence

Datamonitor Healthcare

Ensure your successful entrance into the Type 2 Diabetes market in China

22 Apr 2016

This infographic combines the strengths of Datamonitor Healthcare's China Channel and sister product Citeline's Chinatrove to ensure your successful entrance into the Type 2 Diabetes market in China.

Topics Metabolic

Business and portfolio strategy Competitive and market intelligence

Datamonitor Healthcare

Ready to optimize your opportunities in the Prostate Cancer market?

24 Feb 2016

With the prostate cancer market set to double in value over the next ten years, staying ahead in this competitive market has never been more important.

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: